Clinical Trial Update: Preliminary Safety and Efficacy of the PDS-1.0 in Patients With Neovascular Age Related Macular Degeneration (AMD) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial reports preliminary safety and efficacy results for PDS-1.0 in patients with neovascular age-related macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Neovascular Age-related Macular Degeneration

Drugs mentioned

• PDS-1.0

Snippet

Sponsor: Forsight Vision4 | Conditions: Age-Related Macular Degeneration | Phase 1 | Status: COMPLETED